 | | PRD_002043 | | Name: | Goblin1 | | Formula: | C34 H60 N8 O12 | | Definition date: | 2013-12-04 | | Last modified: | 2022-10-29 |
|
 | | PRD_001156 | | Name: | PL-55 | | Formula: | C41 H67 N9 O12 P S | | Definition date: | 2013-12-11 | | Last modified: | 2013-12-11 |
|
 | | PRD_001159 | | Name: | PL-74 | | Formula: | C46 H74 N10 O13 P S | | Definition date: | 2013-12-11 | | Last modified: | 2013-12-11 |
|
 | | PRD_001211 | | Name: | LEDGF peptide | | Formula: | C27 H45 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2014-03-25 |
|
 | | PRD_001212 | | Name: | LEDGF peptide | | Formula: | C28 H48 N9 O10 S2 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001213 | | Name: | PK(NLE)DN(DVA) peptide | | Formula: | C30 H51 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001214 | | Name: | PKIDN(DPR) peptide | | Formula: | C30 H49 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001157 | | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | | Formula: | C51 H69 N10 O11 | | Definition date: | 2014-01-15 | | Last modified: | 2023-11-03 |
|
 | | PRD_000902 | | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H50 N4 O5 | | Description: | vinylketone carmaphycin analogue VNK1, single bound form | | Definition date: | 2014-01-29 | | Last modified: | 2017-05-04 |
|
 | | PRD_000904 | | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H52 N4 O5 | | Description: | vinylketone carmaphycin analogue VNK1, double bound form | | Definition date: | 2014-01-29 | | Last modified: | 2017-05-04 |
|
 | | PRD_000930 | | Name: | N-hexanoyl-L-valyl-N~1~-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H52 N4 O6 | | Description: | epoxyketone carmaphycin analogue 3, bound form | | Definition date: | 2014-01-29 | | Last modified: | 2023-11-03 |
|
 | | PRD_000956 | | Name: | N-[(2S)-1-({(2S)-1-{[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]amino}-4-[(R)-methylsulfinyl]-1-oxobutan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]hexanamide | | Formula: | C25 H49 N3 O6 S | | Description: | Carmaphycin A, bound form | | Definition date: | 2014-01-29 | | Last modified: | 2023-11-03 |
|
 | | PRD_001166 | | Name: | bicyclic peptide UK749 | | Formula: | C71 H108 N25 O20 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001167 | | Name: | bicyclic peptide UK811 | | Formula: | C74 H119 N26 O22 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001168 | | Name: | bicyclic peptide UK903 | | Formula: | C72 H103 N19 O19 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001135 | | Name: | (CBZ)NPQ(B27) peptide | | Formula: | C26 H38 N6 O8 S | | Definition date: | 2014-02-12 | | Last modified: | 2014-02-12 |
|
 | | PRD_001200 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide | | Formula: | C29 H47 N3 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001201 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-leucinamide | | Formula: | C29 H49 N3 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001205 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide | | Formula: | C33 H48 N4 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001206 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide | | Formula: | C28 H47 N3 O6 S | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001207 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S)-1,2-dihydroxy-5-methylhexan-3-yl]-L-leucinamide | | Formula: | C27 H45 N3 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001210 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide | | Formula: | C26 H43 N3 O5 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_000896 | | Name: | MM-402 | | Formula: | C31 H51 N8 O5 | | Definition date: | 2014-02-19 | | Last modified: | 2023-11-03 |
|
 | | PRD_000897 | | Name: | MM-401 | | Formula: | C29 H47 N8 O5 | | Definition date: | 2014-02-19 | | Last modified: | 2023-11-03 |
|
 | | PRD_001104 | | Name: | cyclic peptide S2iL5 | | Formula: | C90 H126 F3 N27 O23 S | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
